结合蜱源Subolesin与热灭活分枝杆菌的口服疫苗制剂可控制跨物种牛蜱感染
本研究设计对照圈舍试验,评价结合微小扇头蜱源Subolesin(SUB)与热灭活牛分枝杆菌(IV)的口服疫苗制剂对消色扇头蜱和附肢扇头蜱感染的控制效果,并与单独IV、单独SUB及PBS对照比较。结果显示,单独IV、单独SUB及SUB+IV联合口服免疫均有效,其中SUB+IV对消色扇头蜱和附肢扇头蜱的疫苗效力最高(均高于95%)。
要点
- 口服SUB+IV联合制剂对消色扇头蜱和附肢扇头蜱的疫苗效力最高,均高于95%。
- 单独IV、单独SUB及SUB+IV联合口服免疫均对蜱感染有效。
- SUB+IV通过激活多种免疫机制实现有效控制。
核心结论
- 口服SUB+IV联合制剂通过激活多种免疫机制有效控制牛蜱感染。
- 结果支持应用SUB+IV口服疫苗制剂控制扇头蜱属感染以改善动物健康。
研究设计与样本
- 采用对照圈舍试验设计,评价结合消色扇头蜱源SUB与IV的口服制剂对消色扇头蜱和附肢扇头蜱感染的控制效果。
主要发现
- 单独IV、单独SUB及SUB+IV联合口服免疫均对蜱感染有效,消色扇头蜱疫苗效力为71-96%,附肢扇头蜱为87-99%。
- SUB+IV联合制剂的疫苗效力最高,均高于95%。
- 检测了针对SUB和牛分枝杆菌P22的IgG抗体滴度及血清免疫生物标志物(IL-1beta、TNF-alpha、C3)水平,并分析其作为保护相关因素的可能性。
关键数值与推荐
- SUB+IV对消色扇头蜱和附肢扇头蜱的疫苗效力均高于95%。
- 单独IV和单独SUB对消色扇头蜱的疫苗效力为71-96%,对附肢扇头蜱为87-99%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Tick vaccines are necessary as part of a One Health approach for the control of tick infestations and tick-borne diseases. Subolesin (SUB, also known as 4D8) is a tick protective antigen that has shown efficacy in vaccine formulations for the control of ectoparasite infestations and pathogen infection/transmission. A recent proof-of-concept study reported oral vaccination combining Rhipicephalus microplus SUB with heat inactivated Mycobacterium bovis (IV) as an immunostimulant for the control of cattle tick infestations. Based on the efficacy of Rhipicephalus decoloratus SUB for the control of multiple cattle tick species in Uganda, herein we design a controlled pen trial using an oral formulation combining R. decoloratus SUB with IV for the control of R. decoloratus and Rhipicephalus appendiculatus cattle tick infestations. Vaccine efficacy (E) of SUB + IV on tick life cycle was compared with IV and SUB alone and with PBS as control. The IgG antibody titers against SUB and M. bovis P22 and the serum levels of selected protein immune biomarkers (IL-1beta, TNF-alpha, C3) were determined and analyzed as possible correlates of protection. Oral immunization with IV and SUB alone and in SUB + IV combination were effective for the control of tick infestations (E = 71-96% for R. decoloratus and 87-99% for R. appendiculatus) with highest E (higher than 95%) for SUB + IV. The results demonstrated that oral immunization with the SUB + IV formulation resulted in effective control of cattle tick infestations through the activation of multiple immune mechanisms. These results support the application of oral vaccine formulations with SUB + IV for the control of cattle infestations with Rhipicephalus species towards improving animal health.
引用
- Kasaija PD, Contreras M, Kabi F, et al. Oral vaccine formulation combining tick Subolesin with heat inactivated mycobacteria provides control of cross-species cattle tick infestations. Vaccine. 2022. PMID: 35728991. doi:10.1016/j.vaccine.2022.06.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。